Hepatitis B edible vaccine - Boyce Thompson Institute for Plant Research

Drug Profile

Hepatitis B edible vaccine - Boyce Thompson Institute for Plant Research

Latest Information Update: 19 Jan 2007

$50 / €47 *
* $ price applies to USA, Canada and Latin America. € price applies to the rest of the world. Final gross prices may vary according to local VAT.

At a glance

  • Originator Boyce Thompson Institute for Plant Research
  • Class Hepatitis B vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • Discontinued Hepatitis B

Most Recent Events

  • 21 Nov 2000 The Boyce Thompson Institute is seeking a corporate partner for continued development of the edible hepatitis B vaccine (http://bti.cornell.edu/)
  • 05 Jul 2000 The assets and technology of Axis Genetics have been sold to Dow AgroSciences
  • 10 Sep 1999 Axis Genetics has been placed into administration and a buyer is being sought for its business and assets
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top